|
2691 |
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma Enthalten in BMC cancer Bd. 19, 28.5.2019, Nr. 1, date:12.2019: 1-11
|
|
|
2692 |
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma Enthalten in BMC cancer Bd. 16, 25.4.2016, Nr. 1, date:12.2016: 1-10
|
|
|
2693 |
Reference equations for harmonizing gait speed results of different test protocols in community-dwelling older adults Enthalten in Aging clinical and experimental research Bd. 35, 1.12.2022, Nr. 2, date:2.2023: 413-416
|
|
|
2694 |
Regional variation in caesarean deliveries in Germany and its causes Enthalten in BMC pregnancy and childbirth Bd. 13, 1.5.2013, Nr. 1, date:12.2013: 1-8
|
|
|
2695 |
Regionalentwicklung vor dem Hintergrund von Komplexität – praktische Einblicke aus dem echten Norden Enthalten in Standort Bd. 43, 23.7.2019, Nr. 3, date:9.2019: 171-176
|
|
|
2696 |
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease Enthalten in Scientific reports Bd. 12, 15.7.2022, Nr. 1, date:12.2022: 1-15
|
|
|
2697 |
Removing krypton from xenon by cryogenic distillation to the ppq level Enthalten in The European physical journal / C / Particles and fields Bd. 77, 2.5.2017, Nr. 5, date:5.2017: 1-12
|
|
|
2698 |
Responses of blowfly motion-sensitive neurons to reconstructed optic flow along outdoor flight paths Enthalten in Journal of comparative physiology / A / Neuroethology, sensory, neural, and behavioral physiology Bd. 191, 23.8.2005, Nr. 12, date:12.2005: 1143-1155
|
|
|
2699 |
Restriction of diverse retroviruses by SAMHD1 Enthalten in Retrovirology Bd. 10, 5.3.2013, Nr. 1, date:12.2013: 1-12
|
|
|
2700 |
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) Enthalten in Breast cancer research and treatment Bd. 123, 15.7.2010, Nr. 2, date:9.2010: 453-461
|
|